Haleon plc Total Voting Rights and Capital Update

SEC Filing 6-K (0001654954-25-008783)

Haleon plc, a global leader in consumer health, reported its total voting rights and capital as of 31 July 2025. The company has issued 8,987,651,560 ordinary shares of £0.01 each, with 3,880,205 held as treasury shares. This results in 8,983,771,355 ordinary shares with voting rights. Shareholders and others with notification obligations should use this figure as the denominator for calculating their interest in the company under the FCA's Disclosure Guidance and Transparency Rules. Notifiable interests can be sent to [email protected]. Haleon's product portfolio includes Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health and Other, with well-known brands such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu, and Voltaren.